CMS finalizes rule to streamline Medicare prior authorizations

October 02, 2025 An Ruwaito ta hanyar AI

The Centers for Medicare & Medicaid Services (CMS) has finalized a rule to reduce administrative burdens from prior authorization requirements in Medicare Advantage plans. The policy aims to speed up approvals and improve patient access to care. It will affect millions of enrollees starting in 2026.

Federal judge upholds FDA authority over lab-developed tests

October 05, 2025 An Ruwaito ta hanyar AI

A U.S. federal judge has ruled that the Food and Drug Administration (FDA) possesses the authority to regulate lab-developed tests (LDTs) as medical devices. This decision comes amid ongoing debates over the oversight of in-house diagnostic tools used by clinical laboratories.

CMS proposes rule to protect Medicaid enrollees from improper terminations

The Centers for Medicare & Medicaid Services has issued a proposed rule to strengthen safeguards for Medicaid eligibility determinations. This move addresses widespread coverage losses during the post-pandemic unwinding process. The rule aims to ensure states comply with federal requirements for notices and appeals.

Senate confirms Robert Califf as FDA commissioner

The U.S. Senate has confirmed Robert Califf to lead the Food and Drug Administration amid ongoing public health challenges. Califf, a cardiologist with prior FDA experience, was approved in a bipartisan vote. This move aims to stabilize the agency during debates over drug approvals and regulations.